160 related articles for article (PubMed ID: 11135319)
1. Growth factors and their receptors in pancreatic cancer.
Ozawa F; Friess H; Tempia-Caliera A; Kleeff J; Büchler MW
Teratog Carcinog Mutagen; 2001; 21(1):27-44. PubMed ID: 11135319
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer--new aspects of molecular biology research.
Kleeff J; Friess H; Berberat PO; Martignoni ME; Z'graggen K; Büchler MW
Swiss Surg; 2000; 6(5):231-4. PubMed ID: 11077487
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer: factors regulating tumor development, maintenance and metastasis.
Shi X; Friess H; Kleeff J; Ozawa F; Büchler MW
Pancreatology; 2001; 1(5):517-24. PubMed ID: 12120231
[TBL] [Abstract][Full Text] [Related]
4. Molecular aspects of pancreatic cancer and future perspectives.
Friess H; Kleeff J; Korc M; Büchler MW
Dig Surg; 1999; 16(4):281-90. PubMed ID: 10449972
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors.
Friess H; Berberat P; Schilling M; Kunz J; Korc M; Büchler MW
J Mol Med (Berl); 1996 Jan; 74(1):35-42. PubMed ID: 8834768
[TBL] [Abstract][Full Text] [Related]
6. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma.
Liu N; Furukawa T; Kobari M; Tsao MS
Am J Pathol; 1998 Jul; 153(1):263-9. PubMed ID: 9665487
[TBL] [Abstract][Full Text] [Related]
7. Growth factors and cytokines in pancreatic carcinogenesis.
Friess H; Guo XZ; Nan BC; Kleeff J; Büchler MW
Ann N Y Acad Sci; 1999 Jun; 880():110-21. PubMed ID: 10415856
[TBL] [Abstract][Full Text] [Related]
8. Molecular prognostic markers in pancreatic cancer.
Ghaneh P; Kawesha A; Evans JD; Neoptolemos JP
J Hepatobiliary Pancreat Surg; 2002; 9(1):1-11. PubMed ID: 12021893
[TBL] [Abstract][Full Text] [Related]
9. Role of growth factors in pancreatic cancer.
Korc M
Surg Oncol Clin N Am; 1998 Jan; 7(1):25-41. PubMed ID: 9443985
[TBL] [Abstract][Full Text] [Related]
10. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma.
Singh P; Wig JD; Srinivasan R; Radotra BD
Indian J Cancer; 2011; 48(2):170-4. PubMed ID: 21768661
[TBL] [Abstract][Full Text] [Related]
12. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer.
Müller MW; Giese NA; Swiercz JM; Ceyhan GO; Esposito I; Hinz U; Büchler P; Giese T; Büchler MW; Offermanns S; Friess H
Int J Cancer; 2007 Dec; 121(11):2421-33. PubMed ID: 17631638
[TBL] [Abstract][Full Text] [Related]
13. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
14. Signaling pathways in pancreatic cancer.
Reddy SA
Cancer J; 2001; 7(4):274-86. PubMed ID: 11561604
[TBL] [Abstract][Full Text] [Related]
15. A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway.
Holloway S; Davis M; Jaber R; Fleming J
Int J Gastrointest Cancer; 2003; 33(1):61-9. PubMed ID: 12909738
[TBL] [Abstract][Full Text] [Related]
16. Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma.
Röder C; Trauzold A; Kalthoff H
Eur J Cell Biol; 2011; 90(6-7):450-5. PubMed ID: 21129814
[TBL] [Abstract][Full Text] [Related]
17. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer.
Itakura J; Ishiwata T; Shen B; Kornmann M; Korc M
Int J Cancer; 2000 Jan; 85(1):27-34. PubMed ID: 10585578
[TBL] [Abstract][Full Text] [Related]
18. Growth factors and pancreatic cancer.
Korc M
Int J Pancreatol; 1991; 9():87-91. PubMed ID: 1744452
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of molecular alterations in human pancreatic carcinoma--an immunohistological study.
Gansauge F; Gansauge S; Schmidt E; Müller J; Beger HG
Langenbecks Arch Surg; 1998 Apr; 383(2):152-5. PubMed ID: 9641888
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
